Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions
出版年份 2023 全文链接
标题
Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-04-29
DOI
10.1002/med.21968
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
- (2022) Wenli Zhao et al. ACS Chemical Neuroscience
- Principles of Kinase Allosteric Inhibition and Pocket Validation
- (2022) Yue Pan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reversible lysine-targeted probes reveal residence time-based kinase selectivity
- (2022) Tangpo Yang et al. Nature Chemical Biology
- Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules
- (2022) Georg L. Goebel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)
- (2021) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Ring Closure Strategy Leads to Potent RIPK3 Inhibitors
- (2021) Shuwei Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
- (2021) Lijuan Xu et al. CHINESE CHEMICAL LETTERS
- Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors
- (2021) Chunnian Xia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hydrophobic and polar interactions of FDA-approved small molecule protein kinase inhibitors with their target enzymes
- (2021) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Discovery of a cooperative mode of inhibiting RIPK1 kinase
- (2021) Huyan Meng et al. Cell Discovery
- Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
- (2021) Xiangbo Yang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis
- (2021) Yanxiang Meng et al. Nature Communications
- Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
- (2021) Jing Zhu et al. Acta Pharmaceutica Sinica B
- RIP1 kinase activity is critical for skin inflammation but not for viral propagation
- (2020) Joshua D. Webster et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation
- (2020) Xiaoru Duan et al. Cell Death & Disease
- Targeting necroptosis in anticancer therapy: mechanisms and modulators
- (2020) Ying Wu et al. Acta Pharmaceutica Sinica B
- Radiosensitization of human pancreatic cancer by piperlongumine analogues
- (2020) Hao Ma et al. CHINESE CHEMICAL LETTERS
- KLIFS: an overhaul after the first 5 years of supporting kinase research
- (2020) Georgi K Kanev et al. NUCLEIC ACIDS RESEARCH
- Inhibitors of RIP1 kinase: a patent review (2016–present)
- (2020) Philip A. Harris EXPERT OPINION ON THERAPEUTIC PATENTS
- Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
- (2020) Kaijiang Xia et al. Frontiers in Cell and Developmental Biology
- Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models
- (2019) Ting Zhou et al. Cell Death & Disease
- Identification of the Raf kinase inhibitor TAK‐632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3
- (2019) Xiaofei Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
- (2019) Snahel Patel et al. CELL DEATH AND DIFFERENTIATION
- Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
- (2019) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy
- (2019) Hao Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors
- (2019) Ruibin Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage
- (2019) Amy C. Hart et al. ACS Medicinal Chemistry Letters
- Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer
- (2019) Philip A. Harris et al. ACS Medicinal Chemistry Letters
- Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group
- (2019) Gregory L. Hamilton et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis
- (2019) Jue Hou et al. Cell Death & Disease
- Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives
- (2019) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
- (2018) Chalada Suebsuwong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tozasertib Analogues as Inhibitors of Necroptotic Cell Death
- (2018) Sam Hofmans et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships
- (2018) Masato Yoshikawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- Crystal Structure of Ripk4 Reveals Dimerization-Dependent Kinase Activity
- (2018) Christine S. Huang et al. STRUCTURE
- RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
- (2018) Sofie Martens et al. Cell Death & Disease
- Phenytoin inhibits necroptosis
- (2018) Anne von Mässenhausen et al. Cell Death & Disease
- Neuroprotective Effects of DTIO, A Novel Analog of Nec-1, in Acute and Chronic Stages After Ischemic Stroke
- (2018) Wei Li et al. NEUROSCIENCE
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
- (2018) Wei Wang et al. CANCER CELL
- Identification of 5-(2,3-Dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model
- (2018) Yueshan Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium
- (2017) Yu Matsuzawa-Ishimoto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting non-covalent π interactions for catalyst design
- (2017) Andrew J. Neel et al. NATURE
- Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas
- (2017) Robert Roskoski PHARMACOLOGICAL RESEARCH
- RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
- (2017) Dimitry Ofengeim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
- (2016) K Newton et al. CELL DEATH AND DIFFERENTIATION
- Experimental Binding Energies in Supramolecular Complexes
- (2016) Frank Biedermann et al. CHEMICAL REVIEWS
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
- (2016) Yasushi Ito et al. SCIENCE
- Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
- (2015) Peter Canning et al. CHEMISTRY & BIOLOGY
- The diverse role of RIP kinases in necroptosis and inflammation
- (2015) John Silke et al. NATURE IMMUNOLOGY
- A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
- (2015) A Fauster et al. Cell Death & Disease
- Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
- (2015) Malek Najjar et al. Cell Reports
- RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
- (2014) Pratyusha Mandal et al. MOLECULAR CELL
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury
- (2014) J-X Li et al. Cell Death & Disease
- A novel necroptosis inhibitor—necrostatin-21 and its SAR study
- (2013) Zhijie Wu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
- (2013) William J. Kaiser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space
- (2013) Oscar P. J. van Linden et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives
- (2013) Masanori Okaniwa et al. JOURNAL OF MEDICINAL CHEMISTRY
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Structural Basis of RIP1 Inhibition by Necrostatins
- (2013) Tian Xie et al. STRUCTURE
- Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis
- (2013) Philip A. Harris et al. ACS Medicinal Chemistry Letters
- Deciphering the Structural Basis of Eukaryotic Protein Kinase Regulation
- (2013) Hiruy S. Meharena et al. PLOS BIOLOGY
- Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features
- (2012) Zhizhou Fang et al. ACS Chemical Biology
- Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability
- (2012) Sungwoon Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors
- (2012) Vandana Lamba et al. CURRENT PHARMACEUTICAL DESIGN
- Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury
- (2012) Andreas Linkermann et al. KIDNEY INTERNATIONAL
- Many stimuli pull the necrotic trigger, an overview
- (2011) N Vanlangenakker et al. CELL DEATH AND DIFFERENTIATION
- The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation
- (2011) Marion C. Bonnet et al. IMMUNITY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Necroptosis as an alternative form of programmed cell death
- (2010) Dana E Christofferson et al. CURRENT OPINION IN CELL BIOLOGY
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Structure–activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors
- (2008) Xin Teng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure–activity relationship study of a novel necroptosis inhibitor, necrostatin-7
- (2008) Weihong Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A helix scaffold for the assembly of active protein kinases
- (2008) A. P. Kornev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analogous regulatory sites within the αC-β4 loop regions of ZAP-70 tyrosine kinase and AGC kinases
- (2007) Natarajan Kannan et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now